NCT04504773View on ClinicalTrials.gov

Using Immersive Virtual Reality to Treat Pediatric Anxiety

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

January 12, 2022

Study Completion Date

February 14, 2023

Conditions
Specific PhobiaSpecific Phobia, SituationalSpecific Phobia, AnimalSpecific Phobia, Natural EnvironmentChildhood Anxiety Disorder
Interventions
BEHAVIORAL

Virtual Reality Exposure Therapy

Participants will receive a single session of virtual reality exposure therapy that targets the participant's specific phobia stimuli.

Trial Locations (1)

21205

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04504773 - Using Immersive Virtual Reality to Treat Pediatric Anxiety | Biotech Hunter | Biotech Hunter